Thursday, January 8, 2026

CATEGORY

Amneal Pharma

Amneal Advances Migraine Treatment and Launches First Generic GLP-1 Injectable

Amneal Pharmaceuticals, a leading global pharmaceutical company, has made significant strides in its strategic initiatives by resubmitting its new drug application (NDA) for a...

Latest news